HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
HemoGenyx Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Silence Therapeutics Plc | 495.01M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -20.30M |
| Mereo BioPharma Group Plc | 31.54M |
| Compass Pathways Plc | 1.236B |
Enterprise Value Related Metrics
| Earnings Yield | -104.0% |
| Normalized Earnings Yield | -87.36 |